1 Market Overview

1.1 Product Overview and Scope of Lung Cancer Diagnosis and Therapeutics

1.2 Classification of Lung Cancer Diagnosis and Therapeutics by Type

1.2.1 Overview: Global Lung Cancer Diagnosis and Therapeutics Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Lung Cancer Diagnosis and Therapeutics Revenue Market Share by Type in 2021

1.2.3 Non-Small Cell Lung Cancer

1.2.4 Small Cell Lung Cancer

1.3 Global Lung Cancer Diagnosis and Therapeutics Market by Application

1.3.1 Overview: Global Lung Cancer Diagnosis and Therapeutics Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Hospitals

1.3.3 Cancer Research Centers

1.4 Global Lung Cancer Diagnosis and Therapeutics Market Size & Forecast

1.5 Global Lung Cancer Diagnosis and Therapeutics Market Size and Forecast by Region

1.5.1 Global Lung Cancer Diagnosis and Therapeutics Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Lung Cancer Diagnosis and Therapeutics Market Size by Region, (2017-2022)

1.5.3 North America Lung Cancer Diagnosis and Therapeutics Market Size and Prospect (2017-2028)

1.5.4 Europe Lung Cancer Diagnosis and Therapeutics Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Lung Cancer Diagnosis and Therapeutics Market Size and Prospect (2017-2028)

1.5.6 South America Lung Cancer Diagnosis and Therapeutics Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Lung Cancer Diagnosis and Therapeutics Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Lung Cancer Diagnosis and Therapeutics Market Drivers

1.6.2 Lung Cancer Diagnosis and Therapeutics Market Restraints

1.6.3 Lung Cancer Diagnosis and Therapeutics Trends Analysis

2 Company Profiles

2.1 AstraZeneca

2.1.1 AstraZeneca Details

2.1.2 AstraZeneca Major Business

2.1.3 AstraZeneca Lung Cancer Diagnosis and Therapeutics Product and Solutions

2.1.4 AstraZeneca Lung Cancer Diagnosis and Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 AstraZeneca Recent Developments and Future Plans

2.2 Eli Lilly

2.2.1 Eli Lilly Details

2.2.2 Eli Lilly Major Business

2.2.3 Eli Lilly Lung Cancer Diagnosis and Therapeutics Product and Solutions

2.2.4 Eli Lilly Lung Cancer Diagnosis and Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Eli Lilly Recent Developments and Future Plans

2.3 Sanofi

2.3.1 Sanofi Details

2.3.2 Sanofi Major Business

2.3.3 Sanofi Lung Cancer Diagnosis and Therapeutics Product and Solutions

2.3.4 Sanofi Lung Cancer Diagnosis and Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Sanofi Recent Developments and Future Plans

2.4 ArQule

2.4.1 ArQule Details

2.4.2 ArQule Major Business

2.4.3 ArQule Lung Cancer Diagnosis and Therapeutics Product and Solutions

2.4.4 ArQule Lung Cancer Diagnosis and Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 ArQule Recent Developments and Future Plans

2.5 Daiichi Sankyo

2.5.1 Daiichi Sankyo Details

2.5.2 Daiichi Sankyo Major Business

2.5.3 Daiichi Sankyo Lung Cancer Diagnosis and Therapeutics Product and Solutions

2.5.4 Daiichi Sankyo Lung Cancer Diagnosis and Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Daiichi Sankyo Recent Developments and Future Plans

2.6 Celgene

2.6.1 Celgene Details

2.6.2 Celgene Major Business

2.6.3 Celgene Lung Cancer Diagnosis and Therapeutics Product and Solutions

2.6.4 Celgene Lung Cancer Diagnosis and Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Celgene Recent Developments and Future Plans

2.7 Merck

2.7.1 Merck Details

2.7.2 Merck Major Business

2.7.3 Merck Lung Cancer Diagnosis and Therapeutics Product and Solutions

2.7.4 Merck Lung Cancer Diagnosis and Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Merck Recent Developments and Future Plans

2.8 Pfizer

2.8.1 Pfizer Details

2.8.2 Pfizer Major Business

2.8.3 Pfizer Lung Cancer Diagnosis and Therapeutics Product and Solutions

2.8.4 Pfizer Lung Cancer Diagnosis and Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Pfizer Recent Developments and Future Plans

2.9 Boehringer Ingelheim

2.9.1 Boehringer Ingelheim Details

2.9.2 Boehringer Ingelheim Major Business

2.9.3 Boehringer Ingelheim Lung Cancer Diagnosis and Therapeutics Product and Solutions

2.9.4 Boehringer Ingelheim Lung Cancer Diagnosis and Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Boehringer Ingelheim Recent Developments and Future Plans

2.10 Roche

2.10.1 Roche Details

2.10.2 Roche Major Business

2.10.3 Roche Lung Cancer Diagnosis and Therapeutics Product and Solutions

2.10.4 Roche Lung Cancer Diagnosis and Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Roche Recent Developments and Future Plans

2.11 Genentech

2.11.1 Genentech Details

2.11.2 Genentech Major Business

2.11.3 Genentech Lung Cancer Diagnosis and Therapeutics Product and Solutions

2.11.4 Genentech Lung Cancer Diagnosis and Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Genentech Recent Developments and Future Plans

2.12 GSK

2.12.1 GSK Details

2.12.2 GSK Major Business

2.12.3 GSK Lung Cancer Diagnosis and Therapeutics Product and Solutions

2.12.4 GSK Lung Cancer Diagnosis and Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 GSK Recent Developments and Future Plans

2.13 Pharmacyclics

2.13.1 Pharmacyclics Details

2.13.2 Pharmacyclics Major Business

2.13.3 Pharmacyclics Lung Cancer Diagnosis and Therapeutics Product and Solutions

2.13.4 Pharmacyclics Lung Cancer Diagnosis and Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Pharmacyclics Recent Developments and Future Plans

2.14 Novartis

2.14.1 Novartis Details

2.14.2 Novartis Major Business

2.14.3 Novartis Lung Cancer Diagnosis and Therapeutics Product and Solutions

2.14.4 Novartis Lung Cancer Diagnosis and Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 Novartis Recent Developments and Future Plans

2.15 Bayer

2.15.1 Bayer Details

2.15.2 Bayer Major Business

2.15.3 Bayer Lung Cancer Diagnosis and Therapeutics Product and Solutions

2.15.4 Bayer Lung Cancer Diagnosis and Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 Bayer Recent Developments and Future Plans

2.16 Bristol-Myers Squibb

2.16.1 Bristol-Myers Squibb Details

2.16.2 Bristol-Myers Squibb Major Business

2.16.3 Bristol-Myers Squibb Lung Cancer Diagnosis and Therapeutics Product and Solutions

2.16.4 Bristol-Myers Squibb Lung Cancer Diagnosis and Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.16.5 Bristol-Myers Squibb Recent Developments and Future Plans

2.17 Eisai

2.17.1 Eisai Details

2.17.2 Eisai Major Business

2.17.3 Eisai Lung Cancer Diagnosis and Therapeutics Product and Solutions

2.17.4 Eisai Lung Cancer Diagnosis and Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.17.5 Eisai Recent Developments and Future Plans

2.18 AbbVie

2.18.1 AbbVie Details

2.18.2 AbbVie Major Business

2.18.3 AbbVie Lung Cancer Diagnosis and Therapeutics Product and Solutions

2.18.4 AbbVie Lung Cancer Diagnosis and Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.18.5 AbbVie Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Lung Cancer Diagnosis and Therapeutics Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Lung Cancer Diagnosis and Therapeutics Players Market Share in 2021

3.2.2 Top 10 Lung Cancer Diagnosis and Therapeutics Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Lung Cancer Diagnosis and Therapeutics Players Head Office, Products and Services Provided

3.4 Lung Cancer Diagnosis and Therapeutics Mergers & Acquisitions

3.5 Lung Cancer Diagnosis and Therapeutics New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Lung Cancer Diagnosis and Therapeutics Revenue and Market Share by Type (2017-2022)

4.2 Global Lung Cancer Diagnosis and Therapeutics Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Lung Cancer Diagnosis and Therapeutics Revenue Market Share by Application (2017-2022)

5.2 Global Lung Cancer Diagnosis and Therapeutics Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Lung Cancer Diagnosis and Therapeutics Revenue by Type (2017-2028)

6.2 North America Lung Cancer Diagnosis and Therapeutics Revenue by Application (2017-2028)

6.3 North America Lung Cancer Diagnosis and Therapeutics Market Size by Country

6.3.1 North America Lung Cancer Diagnosis and Therapeutics Revenue by Country (2017-2028)

6.3.2 United States Lung Cancer Diagnosis and Therapeutics Market Size and Forecast (2017-2028)

6.3.3 Canada Lung Cancer Diagnosis and Therapeutics Market Size and Forecast (2017-2028)

6.3.4 Mexico Lung Cancer Diagnosis and Therapeutics Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Lung Cancer Diagnosis and Therapeutics Revenue by Type (2017-2028)

7.2 Europe Lung Cancer Diagnosis and Therapeutics Revenue by Application (2017-2028)

7.3 Europe Lung Cancer Diagnosis and Therapeutics Market Size by Country

7.3.1 Europe Lung Cancer Diagnosis and Therapeutics Revenue by Country (2017-2028)

7.3.2 Germany Lung Cancer Diagnosis and Therapeutics Market Size and Forecast (2017-2028)

7.3.3 France Lung Cancer Diagnosis and Therapeutics Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Lung Cancer Diagnosis and Therapeutics Market Size and Forecast (2017-2028)

7.3.5 Russia Lung Cancer Diagnosis and Therapeutics Market Size and Forecast (2017-2028)

7.3.6 Italy Lung Cancer Diagnosis and Therapeutics Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Lung Cancer Diagnosis and Therapeutics Revenue by Type (2017-2028)

8.2 Asia-Pacific Lung Cancer Diagnosis and Therapeutics Revenue by Application (2017-2028)

8.3 Asia-Pacific Lung Cancer Diagnosis and Therapeutics Market Size by Region

8.3.1 Asia-Pacific Lung Cancer Diagnosis and Therapeutics Revenue by Region (2017-2028)

8.3.2 China Lung Cancer Diagnosis and Therapeutics Market Size and Forecast (2017-2028)

8.3.3 Japan Lung Cancer Diagnosis and Therapeutics Market Size and Forecast (2017-2028)

8.3.4 South Korea Lung Cancer Diagnosis and Therapeutics Market Size and Forecast (2017-2028)

8.3.5 India Lung Cancer Diagnosis and Therapeutics Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Lung Cancer Diagnosis and Therapeutics Market Size and Forecast (2017-2028)

8.3.7 Australia Lung Cancer Diagnosis and Therapeutics Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Lung Cancer Diagnosis and Therapeutics Revenue by Type (2017-2028)

9.2 South America Lung Cancer Diagnosis and Therapeutics Revenue by Application (2017-2028)

9.3 South America Lung Cancer Diagnosis and Therapeutics Market Size by Country

9.3.1 South America Lung Cancer Diagnosis and Therapeutics Revenue by Country (2017-2028)

9.3.2 Brazil Lung Cancer Diagnosis and Therapeutics Market Size and Forecast (2017-2028)

9.3.3 Argentina Lung Cancer Diagnosis and Therapeutics Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Lung Cancer Diagnosis and Therapeutics Revenue by Type (2017-2028)

10.2 Middle East & Africa Lung Cancer Diagnosis and Therapeutics Revenue by Application (2017-2028)

10.3 Middle East & Africa Lung Cancer Diagnosis and Therapeutics Market Size by Country

10.3.1 Middle East & Africa Lung Cancer Diagnosis and Therapeutics Revenue by Country (2017-2028)

10.3.2 Turkey Lung Cancer Diagnosis and Therapeutics Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Lung Cancer Diagnosis and Therapeutics Market Size and Forecast (2017-2028)

10.3.4 UAE Lung Cancer Diagnosis and Therapeutics Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Lung Cancer Diagnosis and Therapeutics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Lung Cancer Diagnosis and Therapeutics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Lung Cancer Diagnosis and Therapeutics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Lung Cancer Diagnosis and Therapeutics Revenue (USD Million) by Region (2017-2022)

Table 5. Global Lung Cancer Diagnosis and Therapeutics Revenue Market Share by Region (2023-2028)

Table 6. AstraZeneca Corporate Information, Head Office, and Major Competitors

Table 7. AstraZeneca Major Business

Table 8. AstraZeneca Lung Cancer Diagnosis and Therapeutics Product and Solutions

Table 9. AstraZeneca Lung Cancer Diagnosis and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Eli Lilly Corporate Information, Head Office, and Major Competitors

Table 11. Eli Lilly Major Business

Table 12. Eli Lilly Lung Cancer Diagnosis and Therapeutics Product and Solutions

Table 13. Eli Lilly Lung Cancer Diagnosis and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Sanofi Corporate Information, Head Office, and Major Competitors

Table 15. Sanofi Major Business

Table 16. Sanofi Lung Cancer Diagnosis and Therapeutics Product and Solutions

Table 17. Sanofi Lung Cancer Diagnosis and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. ArQule Corporate Information, Head Office, and Major Competitors

Table 19. ArQule Major Business

Table 20. ArQule Lung Cancer Diagnosis and Therapeutics Product and Solutions

Table 21. ArQule Lung Cancer Diagnosis and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Daiichi Sankyo Corporate Information, Head Office, and Major Competitors

Table 23. Daiichi Sankyo Major Business

Table 24. Daiichi Sankyo Lung Cancer Diagnosis and Therapeutics Product and Solutions

Table 25. Daiichi Sankyo Lung Cancer Diagnosis and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Celgene Corporate Information, Head Office, and Major Competitors

Table 27. Celgene Major Business

Table 28. Celgene Lung Cancer Diagnosis and Therapeutics Product and Solutions

Table 29. Celgene Lung Cancer Diagnosis and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Merck Corporate Information, Head Office, and Major Competitors

Table 31. Merck Major Business

Table 32. Merck Lung Cancer Diagnosis and Therapeutics Product and Solutions

Table 33. Merck Lung Cancer Diagnosis and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Pfizer Corporate Information, Head Office, and Major Competitors

Table 35. Pfizer Major Business

Table 36. Pfizer Lung Cancer Diagnosis and Therapeutics Product and Solutions

Table 37. Pfizer Lung Cancer Diagnosis and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors

Table 39. Boehringer Ingelheim Major Business

Table 40. Boehringer Ingelheim Lung Cancer Diagnosis and Therapeutics Product and Solutions

Table 41. Boehringer Ingelheim Lung Cancer Diagnosis and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Roche Corporate Information, Head Office, and Major Competitors

Table 43. Roche Major Business

Table 44. Roche Lung Cancer Diagnosis and Therapeutics Product and Solutions

Table 45. Roche Lung Cancer Diagnosis and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Genentech Corporate Information, Head Office, and Major Competitors

Table 47. Genentech Major Business

Table 48. Genentech Lung Cancer Diagnosis and Therapeutics Product and Solutions

Table 49. Genentech Lung Cancer Diagnosis and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. GSK Corporate Information, Head Office, and Major Competitors

Table 51. GSK Major Business

Table 52. GSK Lung Cancer Diagnosis and Therapeutics Product and Solutions

Table 53. GSK Lung Cancer Diagnosis and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Pharmacyclics Corporate Information, Head Office, and Major Competitors

Table 55. Pharmacyclics Major Business

Table 56. Pharmacyclics Lung Cancer Diagnosis and Therapeutics Product and Solutions

Table 57. Pharmacyclics Lung Cancer Diagnosis and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Novartis Corporate Information, Head Office, and Major Competitors

Table 59. Novartis Major Business

Table 60. Novartis Lung Cancer Diagnosis and Therapeutics Product and Solutions

Table 61. Novartis Lung Cancer Diagnosis and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Bayer Corporate Information, Head Office, and Major Competitors

Table 63. Bayer Major Business

Table 64. Bayer Lung Cancer Diagnosis and Therapeutics Product and Solutions

Table 65. Bayer Lung Cancer Diagnosis and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors

Table 67. Bristol-Myers Squibb Major Business

Table 68. Bristol-Myers Squibb Lung Cancer Diagnosis and Therapeutics Product and Solutions

Table 69. Bristol-Myers Squibb Lung Cancer Diagnosis and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 70. Eisai Corporate Information, Head Office, and Major Competitors

Table 71. Eisai Major Business

Table 72. Eisai Lung Cancer Diagnosis and Therapeutics Product and Solutions

Table 73. Eisai Lung Cancer Diagnosis and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 74. AbbVie Corporate Information, Head Office, and Major Competitors

Table 75. AbbVie Major Business

Table 76. AbbVie Lung Cancer Diagnosis and Therapeutics Product and Solutions

Table 77. AbbVie Lung Cancer Diagnosis and Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 78. Global Lung Cancer Diagnosis and Therapeutics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 79. Global Lung Cancer Diagnosis and Therapeutics Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 80. Breakdown of Lung Cancer Diagnosis and Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)

Table 81. Lung Cancer Diagnosis and Therapeutics Players Head Office, Products and Services Provided

Table 82. Lung Cancer Diagnosis and Therapeutics Mergers & Acquisitions in the Past Five Years

Table 83. Lung Cancer Diagnosis and Therapeutics New Entrants and Expansion Plans

Table 84. Global Lung Cancer Diagnosis and Therapeutics Revenue (USD Million) by Type (2017-2022)

Table 85. Global Lung Cancer Diagnosis and Therapeutics Revenue Share by Type (2017-2022)

Table 86. Global Lung Cancer Diagnosis and Therapeutics Revenue Forecast by Type (2023-2028)

Table 87. Global Lung Cancer Diagnosis and Therapeutics Revenue by Application (2017-2022)

Table 88. Global Lung Cancer Diagnosis and Therapeutics Revenue Forecast by Application (2023-2028)

Table 89. North America Lung Cancer Diagnosis and Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 90. North America Lung Cancer Diagnosis and Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 91. North America Lung Cancer Diagnosis and Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 92. North America Lung Cancer Diagnosis and Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 93. North America Lung Cancer Diagnosis and Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 94. North America Lung Cancer Diagnosis and Therapeutics Revenue by Country (2023-2028) & (USD Million)

Table 95. Europe Lung Cancer Diagnosis and Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 96. Europe Lung Cancer Diagnosis and Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 97. Europe Lung Cancer Diagnosis and Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 98. Europe Lung Cancer Diagnosis and Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 99. Europe Lung Cancer Diagnosis and Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 100. Europe Lung Cancer Diagnosis and Therapeutics Revenue by Country (2023-2028) & (USD Million)

Table 101. Asia-Pacific Lung Cancer Diagnosis and Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 102. Asia-Pacific Lung Cancer Diagnosis and Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 103. Asia-Pacific Lung Cancer Diagnosis and Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 104. Asia-Pacific Lung Cancer Diagnosis and Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 105. Asia-Pacific Lung Cancer Diagnosis and Therapeutics Revenue by Region (2017-2022) & (USD Million)

Table 106. Asia-Pacific Lung Cancer Diagnosis and Therapeutics Revenue by Region (2023-2028) & (USD Million)

Table 107. South America Lung Cancer Diagnosis and Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 108. South America Lung Cancer Diagnosis and Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 109. South America Lung Cancer Diagnosis and Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 110. South America Lung Cancer Diagnosis and Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 111. South America Lung Cancer Diagnosis and Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 112. South America Lung Cancer Diagnosis and Therapeutics Revenue by Country (2023-2028) & (USD Million)

Table 113. Middle East & Africa Lung Cancer Diagnosis and Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 114. Middle East & Africa Lung Cancer Diagnosis and Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 115. Middle East & Africa Lung Cancer Diagnosis and Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 116. Middle East & Africa Lung Cancer Diagnosis and Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 117. Middle East & Africa Lung Cancer Diagnosis and Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 118. Middle East & Africa Lung Cancer Diagnosis and Therapeutics Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Lung Cancer Diagnosis and Therapeutics Picture

Figure 2. Global Lung Cancer Diagnosis and Therapeutics Revenue Market Share by Type in 2021

Figure 3. Non-Small Cell Lung Cancer

Figure 4. Small Cell Lung Cancer

Figure 5. Lung Cancer Diagnosis and Therapeutics Revenue Market Share by Application in 2021

Figure 6. Hospitals Picture

Figure 7. Cancer Research Centers Picture

Figure 8. Global Lung Cancer Diagnosis and Therapeutics Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 9. Global Lung Cancer Diagnosis and Therapeutics Revenue and Forecast (2017-2028) & (USD Million)

Figure 10. Global Lung Cancer Diagnosis and Therapeutics Revenue Market Share by Region (2017-2028)

Figure 11. Global Lung Cancer Diagnosis and Therapeutics Revenue Market Share by Region in 2021

Figure 12. North America Lung Cancer Diagnosis and Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 13. Europe Lung Cancer Diagnosis and Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 14. Asia-Pacific Lung Cancer Diagnosis and Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. South America Lung Cancer Diagnosis and Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. Middle East and Africa Lung Cancer Diagnosis and Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Lung Cancer Diagnosis and Therapeutics Market Drivers

Figure 18. Lung Cancer Diagnosis and Therapeutics Market Restraints

Figure 19. Lung Cancer Diagnosis and Therapeutics Market Trends

Figure 20. AstraZeneca Recent Developments and Future Plans

Figure 21. Eli Lilly Recent Developments and Future Plans

Figure 22. Sanofi Recent Developments and Future Plans

Figure 23. ArQule Recent Developments and Future Plans

Figure 24. Daiichi Sankyo Recent Developments and Future Plans

Figure 25. Celgene Recent Developments and Future Plans

Figure 26. Merck Recent Developments and Future Plans

Figure 27. Pfizer Recent Developments and Future Plans

Figure 28. Boehringer Ingelheim Recent Developments and Future Plans

Figure 29. Roche Recent Developments and Future Plans

Figure 30. Genentech Recent Developments and Future Plans

Figure 31. GSK Recent Developments and Future Plans

Figure 32. Pharmacyclics Recent Developments and Future Plans

Figure 33. Novartis Recent Developments and Future Plans

Figure 34. Bayer Recent Developments and Future Plans

Figure 35. Bristol-Myers Squibb Recent Developments and Future Plans

Figure 36. Eisai Recent Developments and Future Plans

Figure 37. AbbVie Recent Developments and Future Plans

Figure 38. Global Lung Cancer Diagnosis and Therapeutics Revenue Share by Players in 2021

Figure 39. Lung Cancer Diagnosis and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 40. Global Top 3 Players Lung Cancer Diagnosis and Therapeutics Revenue Market Share in 2021

Figure 41. Global Top 10 Players Lung Cancer Diagnosis and Therapeutics Revenue Market Share in 2021

Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 43. Global Lung Cancer Diagnosis and Therapeutics Revenue Share by Type in 2021

Figure 44. Global Lung Cancer Diagnosis and Therapeutics Market Share Forecast by Type (2023-2028)

Figure 45. Global Lung Cancer Diagnosis and Therapeutics Revenue Share by Application in 2021

Figure 46. Global Lung Cancer Diagnosis and Therapeutics Market Share Forecast by Application (2023-2028)

Figure 47. North America Lung Cancer Diagnosis and Therapeutics Sales Market Share by Type (2017-2028)

Figure 48. North America Lung Cancer Diagnosis and Therapeutics Sales Market Share by Application (2017-2028)

Figure 49. North America Lung Cancer Diagnosis and Therapeutics Revenue Market Share by Country (2017-2028)

Figure 50. United States Lung Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Canada Lung Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. Mexico Lung Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. Europe Lung Cancer Diagnosis and Therapeutics Sales Market Share by Type (2017-2028)

Figure 54. Europe Lung Cancer Diagnosis and Therapeutics Sales Market Share by Application (2017-2028)

Figure 55. Europe Lung Cancer Diagnosis and Therapeutics Revenue Market Share by Country (2017-2028)

Figure 56. Germany Lung Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. France Lung Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. United Kingdom Lung Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Russia Lung Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Italy Lung Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Asia-Pacific Lung Cancer Diagnosis and Therapeutics Sales Market Share by Type (2017-2028)

Figure 62. Asia-Pacific Lung Cancer Diagnosis and Therapeutics Sales Market Share by Application (2017-2028)

Figure 63. Asia-Pacific Lung Cancer Diagnosis and Therapeutics Revenue Market Share by Region (2017-2028)

Figure 64. China Lung Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Japan Lung Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. South Korea Lung Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. India Lung Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Southeast Asia Lung Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Australia Lung Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. South America Lung Cancer Diagnosis and Therapeutics Sales Market Share by Type (2017-2028)

Figure 71. South America Lung Cancer Diagnosis and Therapeutics Sales Market Share by Application (2017-2028)

Figure 72. South America Lung Cancer Diagnosis and Therapeutics Revenue Market Share by Country (2017-2028)

Figure 73. Brazil Lung Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Argentina Lung Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Middle East and Africa Lung Cancer Diagnosis and Therapeutics Sales Market Share by Type (2017-2028)

Figure 76. Middle East and Africa Lung Cancer Diagnosis and Therapeutics Sales Market Share by Application (2017-2028)

Figure 77. Middle East and Africa Lung Cancer Diagnosis and Therapeutics Revenue Market Share by Country (2017-2028)

Figure 78. Turkey Lung Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 79. Saudi Arabia Lung Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 80. UAE Lung Cancer Diagnosis and Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 81. Methodology

Figure 82. Research Process and Data Source